http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2014, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 17 Apr 2007 08:37:46 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/FDA/Adherex+%28ADH%29+Announces+2+Presentations+of+ADH-1+Data+at+Annual+Meeting/2048198.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Adherex+%28ADH%29+Announces+2+Presentations+of+ADH-1+Data+at+Annual+Meeting/2048198.html for the full story. http://www.streetinsider.com/FDA/Adherex+%28ADH%29+Announces+2+Presentations+of+ADH-1+Data+at+Annual+Meeting/2048198.html Tue, 17 Apr 2007 08:37:46 -0500 ADH http://www.streetinsider.com/FDA/Adherex+Technologies+%28ADX%29+Initiates+Phase+I+Combination+Trials+for+Treatment+of+Melanoma/1915821.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Adherex+Technologies+%28ADX%29+Initiates+Phase+I+Combination+Trials+for+Treatment+of+Melanoma/1915821.html for the full story. http://www.streetinsider.com/FDA/Adherex+Technologies+%28ADX%29+Initiates+Phase+I+Combination+Trials+for+Treatment+of+Melanoma/1915821.html Tue, 27 Mar 2007 08:39:06 -0500 ADH http://www.streetinsider.com/Corporate+News/Adherex+Technologies+%28ADH%29+Regains+All+Rights+to+ADH-1+and+Will+Continue+Clinical+Development/1249391.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adherex+Technologies+%28ADH%29+Regains+All+Rights+to+ADH-1+and+Will+Continue+Clinical+Development/1249391.html for the full story. http://www.streetinsider.com/Corporate+News/Adherex+Technologies+%28ADH%29+Regains+All+Rights+to+ADH-1+and+Will+Continue+Clinical+Development/1249391.html Wed, 11 Oct 2006 09:13:17 -0500 GSK ADH http://www.streetinsider.com/Corporate+News/Adherex+Technologies+%28ADH%29+Regains+All+Rights+to+ADH-1+and+Will+Continue+Clinical+Development/1249391.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adherex+Technologies+%28ADH%29+Regains+All+Rights+to+ADH-1+and+Will+Continue+Clinical+Development/1249391.html for the full story. http://www.streetinsider.com/Corporate+News/Adherex+Technologies+%28ADH%29+Regains+All+Rights+to+ADH-1+and+Will+Continue+Clinical+Development/1249391.html Wed, 11 Oct 2006 09:13:17 -0500 GSK ADH http://www.streetinsider.com/FDA/Receives+FDA+Orphan+Drug+Designation+for+Eniluracil+in+Liver+Cancer/465485.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Receives+FDA+Orphan+Drug+Designation+for+Eniluracil+in+Liver+Cancer/465485.html for the full story. http://www.streetinsider.com/FDA/Receives+FDA+Orphan+Drug+Designation+for+Eniluracil+in+Liver+Cancer/465485.html Wed, 21 Dec 2005 08:26:01 -0500 ADH http://www.streetinsider.com/FDA/ADH+Receives+Investigational+New+Drug+%27IND%27+Clearance/406763.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/ADH+Receives+Investigational+New+Drug+%27IND%27+Clearance/406763.html for the full story. http://www.streetinsider.com/FDA/ADH+Receives+Investigational+New+Drug+%27IND%27+Clearance/406763.html Mon, 28 Nov 2005 08:42:35 -0500 ADH http://www.streetinsider.com/FDA/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html for the full story. http://www.streetinsider.com/FDA/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Fri, 15 Jul 2005 07:33:14 -0500 ADH GSK http://www.streetinsider.com/Hot+List/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+List/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html for the full story. http://www.streetinsider.com/Hot+List/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Fri, 15 Jul 2005 07:33:14 -0500 ADH GSK http://www.streetinsider.com/FDA/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html for the full story. http://www.streetinsider.com/FDA/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Fri, 15 Jul 2005 07:33:14 -0500 ADH GSK http://www.streetinsider.com/Hot+List/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+List/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html for the full story. http://www.streetinsider.com/Hot+List/ADH+Announces+Licensing+Deal+With+GlaxoSmithKline/87451.html Fri, 15 Jul 2005 07:33:14 -0500 ADH GSK http://www.streetinsider.com/FDA/ADH+Receives+Clearance+For+Phase+II+Trial+Of+ADH-1/7119.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/ADH+Receives+Clearance+For+Phase+II+Trial+Of+ADH-1/7119.html for the full story. http://www.streetinsider.com/FDA/ADH+Receives+Clearance+For+Phase+II+Trial+Of+ADH-1/7119.html Thu, 24 Mar 2005 08:13:39 -0500 ADH http://www.streetinsider.com/FDA/ADH+and+National+Cancer+Institute+to+Collaborate+on+Clinical+Development+of+ADH-1+Exherin/5591.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/ADH+and+National+Cancer+Institute+to+Collaborate+on+Clinical+Development+of+ADH-1+Exherin/5591.html for the full story. http://www.streetinsider.com/FDA/ADH+and+National+Cancer+Institute+to+Collaborate+on+Clinical+Development+of+ADH-1+Exherin/5591.html Fri, 11 Mar 2005 08:03:48 -0500 ADH